{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:30:51Z","timestamp":1792096251809,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-017-3926-9","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T07:23:09Z","timestamp":1515396189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Health services research in patients with breast cancer (CAMISS-prospective): study protocol for an observational prospective study"],"prefix":"10.1186","volume":"18","author":[{"name":"on behalf of REDISSEC-CaMISS group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-2479","authenticated-orcid":false,"given":"Susana","family":"Garc\u00eda-Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sarasqueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Legarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximino","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Serrano-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"key":"3926_CR1","unstructured":"Globocan 2012. (Accessed on December 12. Fast Stats. Most frequent cancers: both sexes 2012 [\nhttp:\/\/globocan.iarc.fr\/old\/bar_sex_site_prev.asp?selection=3152&title=Breast&statistic=3&populations=6&window=1&grid=1&color1=5&color1e=&color2=4&color2e=&submit=%C2%A0Execute%C2%A0\n\n]."},{"issue":"6","key":"3926_CR2","doi-asserted-by":"crossref","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","volume":"107","author":"BA Kohler","year":"2015","unstructured":"Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3926_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/cjp2.32","volume":"2","author":"AR Green","year":"2016","unstructured":"Green AR, Soria D, Stephen J, Powe DG, Nolan CC, Kunkler I, et al. Nottingham prognostic index plus: validation of a clinical decision making tool in breast cancer in an independent series. J Pathol Clin Res. 2016;2(1):32\u201340.","journal-title":"J Pathol Clin Res"},{"issue":"11","key":"3926_CR4","doi-asserted-by":"crossref","first-page":"e27446","DOI":"10.1371\/journal.pone.0027446","volume":"6","author":"D Hajage","year":"2011","unstructured":"Hajage D, de Rycke Y, Bollet M, Savignoni A, Caly M, Pierga JY, et al. External validation of adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement. PLoS One. 2011;6(11):e27446.","journal-title":"PLoS One"},{"issue":"5","key":"3926_CR5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/bjc.2012.338","volume":"107","author":"GC Wishart","year":"2012","unstructured":"Wishart GC, Bajdik CD, Dicks E, Provenzano E, Schmidt MK, Sherman M, et al. PREDICT plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer. 2012;107(5):800\u20137.","journal-title":"Br J Cancer"},{"key":"3926_CR6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/2193-1801-2-391","volume":"2","author":"L Chee Khoon","year":"2013","unstructured":"Chee Khoon L, Val JG, Alan SC, Anne-Sophie V, Vernon H, Martin Hn T, et al. Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone. SpringerPlus. 2013;2:391.","journal-title":"SpringerPlus"},{"key":"3926_CR7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12955-016-0449-z","volume":"14","author":"S Emily Nash","year":"2016","unstructured":"Emily Nash S, Wei S, Lee B, Patrick P, William J, Allen M, et al. Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes. 2016;14:52.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"3926_CR8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12032-011-9844-9","volume":"29","author":"S Helene","year":"2012","unstructured":"Helene S, Thomas H, Hemming J, Zakaria E, Yvonne B. Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer. Med Oncol (Northwood, London, England). 2012;29(2):432.","journal-title":"Med Oncol (Northwood, London, England)"},{"key":"3926_CR9","doi-asserted-by":"crossref","first-page":"970780","DOI":"10.1155\/2014\/970780","volume":"2014","author":"RI Griffiths","year":"2014","unstructured":"Griffiths RI, Gleeson ML, Valderas JM, Danese MD. Impact of undetected comorbidity on treatment and outcomes of breast cancer. Int J Breast Cancer. 2014;2014:970780.","journal-title":"Int J Breast Cancer"},{"issue":"1","key":"3926_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-014-2917-7","volume":"145","author":"M Kiderlen","year":"2014","unstructured":"Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJ, Guicherit OR, et al. Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study. Breast Cancer Res Treat. 2014;145(1):185\u201392.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3926_CR11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jgs.12687","volume":"62","author":"G Kimmick","year":"2014","unstructured":"Kimmick G, Fleming ST, Sabatino SA, Wu XC, Hwang W, Wilson JF, et al. Comorbidity burden and guideline-concordant care for breast cancer. J Am Geriatr Soc. 2014;62(3):482\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"3926_CR12","unstructured":"REDISSEC. CAMISS: Investigaci\u00f3n en servicios sanitarios en C\u00e1ncer de Mama [Available from: \nhttp:\/\/www.camiss.info\/\n\n. Accessed 1 June 2017."},{"issue":"1","key":"3926_CR13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12885-016-2768-1","volume":"16","author":"A Romero","year":"2016","unstructured":"Romero A, Tor\u00e0-Rocamora I, Bar\u00e9 M, Barata T, Domingo L, Ferrer J, Tor\u00e0 N, Comas M, Merenciano C, Maci\u00e0 F, Castells X, Sala M, CAMISS Study Group. Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs. BMC Cancer. 2016;16(1):735.","journal-title":"BMC Cancer"},{"issue":"4","key":"3926_CR14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/annonc\/mdm481","volume":"19","author":"N Perry","year":"2008","unstructured":"Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. Ann Oncol. 2008;19(4):614\u201322.","journal-title":"Ann Oncol"},{"issue":"3","key":"3926_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1179\/acb.2008.028","volume":"63","author":"E Kellen","year":"2008","unstructured":"Kellen E, et al. Interval cancers in the beginning years of the breast cancer screening programme in the Belgian province of Limburg. Acta Clin Belg. 2008;63(3):179\u201384.","journal-title":"Acta Clin Belg"},{"issue":"5","key":"3926_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"3926_CR17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.breast.2012.07.006","volume":"21","author":"ML Marinovich","year":"2012","unstructured":"Marinovich ML, Sardanelli F, Ciatto S, Mamounas E, Brennan M, Macaskill P, et al. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast. 2012;21(5):669\u201377.","journal-title":"Breast"},{"issue":"5","key":"3926_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3926_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pon.555","volume":"11","author":"JI Arraras","year":"2002","unstructured":"Arraras JI, Arias F, Tejedor M, Pruja E, Marcos M, Martinez E, et al. The EORTC QLQ-C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patients. Psychooncology. 2002;11(3):249\u201356.","journal-title":"Psychooncology"},{"issue":"10","key":"3926_CR20","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","volume":"14","author":"MA Sprangers","year":"1996","unstructured":"Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756\u201368.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3926_CR21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"6","key":"3926_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"3926_CR23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1600-0447.2003.00062.x","volume":"107","author":"JM Quintana","year":"2003","unstructured":"Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the hospital anxiety and depression scale. Acta Psychiatr Scand. 2003;107(3):216\u201321.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"3926_CR24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710\u20138.","journal-title":"Am J Epidemiol"},{"issue":"13","key":"3926_CR25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.medcli.2009.03.036","volume":"133","author":"C Sarasqueta","year":"2009","unstructured":"Sarasqueta C, Martinez-Camblor P, Mendiola A, Martinez-Pueyo I, Michelena MJ, Basterretxea M, et al. Breast cancer relative survival after the first recurrence and related prognostic factors. Med Clin (Barc). 2009;133(13):489\u201395.","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"3926_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.breast.2014.11.012","volume":"24","author":"MJ Yuste Sanchez","year":"2015","unstructured":"Yuste Sanchez MJ, Torres Lacomba M, Sanchez Sanchez B, Prieto Merino D, Pacheco da Costa S, Cerezo Tellez E, et al. Health related quality of life improvement in breast cancer patients: secondary outcome from a simple blinded, randomised clinical trial. Breast. 2015;24(1):75\u201381.","journal-title":"Breast"},{"key":"3926_CR27","unstructured":"Cancer. AJCo. Breast Cancer Staging 7th edn. 2009 [Available from: \nhttps:\/\/cancerstaging.org\/references-tools\/quickreferences\/Documents\/BreastMedium.pdf\n\n. Accessed 1 June 2017."},{"issue":"5","key":"3926_CR28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0000000000000072","volume":"22","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Collins GS. New guideline for the reporting of studies developing, validating, or updating a multivariable clinical prediction model: the TRIPOD statement. Adv Anat Pathol. 2015;22(5):303\u20135.","journal-title":"Adv Anat Pathol"},{"key":"3926_CR29","unstructured":"Network R-HSROCP. CAMISS- Investigaci\u00f3n en servicios sanitarios en c\u00e1ncer de mama 2017 [Available from: \nhttp:\/\/www.CaMISS.info\/\n\n. Accessed 1 June 2017."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T07:23:31Z","timestamp":1515396211000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3926-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3926-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,8]]},"article-number":"54"}}